We welcome talented individuals who embrace our commitment to patients in need and share our values. Our success is determined by collective diversity of thoughts, skills and experiences.
As a team, we foster innovation in all forms as we collectively strive to discover and develop new approaches to treating severe rare diseases.
At our core, we dive deep into the science of severe rare diseases, holding ourselves to the highest scientific standards and best practices to bring those discoveries through approval and to patients in need.
The patients we serve are very ill. We will not waiver in our commitment to them, their families and their healthcare providers.
Drug development takes a village, and we know we cannot succeed unless our entire team and partners join together to bring therapies from discovery into patients’ hands.
We value diversity of professions, backgrounds and cultures, understanding that each of us has a respected insight and perspective on our work and our vision.
Our team is built on agility and flexibility, adjusting to opportunities and needs of the business quickly and comfortably.
SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded biotechnology company dedicated to advancing innovative solutions for severe rare diseases. Our new asset, SCY-770 is being developed for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) and has been granted Orphan Drug designation. SCYNEXIS’s proprietary antifungal platform “fungerps” includes BREXAFEMME® (ibrexafungerp tablets), the first approved representative of this novel class, which has been licensed to GSK, and SCY-247 which is currently in a Phase 1 stage of development.
We are seeking a capable, insightful, experienced Senior Director, Regulatory Affairs, to be based in our Jersey City, NJ office. We are committed to positively impacting the lives of patients by developing innovative therapies, come join us and make a difference.
The Senior Director, Regulatory Affairs is responsible for providing subject matter expertise on matters related to global regulatory activities, as well as providing leadership for the growth and responsibilities of the regulatory department. The Senior Director will represent SCYNEXIS in key stakeholder and strategy meetings on regulatory matters related to medical product development and commercialization, including meetings with executive leadership, meetings with the Food and Drug Administration (FDA) and other regulators. This role leads preparation, review, and submission of documents to the FDA and other regulatory authorities to support product development leading to marketing authorization and lifecycle management. This role combines scientific, regulatory, and business knowledge to assure that SCYNEXIS products are developed and distributed according to all applicable regulations in alignment with the company’s strategic goals. The role requires a mastery of medical product regulations to develop efficient solutions to the evolving regulatory needs of the industry.
SCYNEXIS is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status or other characteristics protected by law.
The starting pay for this role is between $235,000.00 and $275,000.00. The estimated salary range represents an anticipated range for this position. The actual base salary offered may vary based on a variety of factors.
We offer a competitive total rewards package that includes short-term and long-term incentive programs and a comprehensive benefits package, including medical, dental, and vision coverage, a 401(k) with company match, paid time off, and additional benefits.
SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded, clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare diseases. Our pipeline includes two clinical-stage compounds: SCY-770, a novel, highly selective direct AMPK activator in development for autosomal dominant polycystic kidney disease (ADPKD), and SCY-247, a second-generation triterpenoid antifungal candidate currently in Phase 1 development for the treatment and prevention of invasive fungal infections.
We are seeking an experienced Director, Drug Product Development, to be based in our Jersey City, NJ office. This role will lead drug product strategy and execution across our clinical-stage portfolio, supporting the advancement of innovative therapies for patients with serious rare diseases.
The Director, Drug Product Development will lead formulation, manufacturing, and lifecycle activities for drug product candidates from development through clinical-stage execution. This role partners across CMC, Quality, Regulatory, Supply Chain, and external manufacturers to ensure drug products are robust, scalable, and aligned with program timelines and regulatory requirements.
SCYNEXIS is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status or other characteristics protected by law.
The starting pay for this role is between $200,000.00 and $235,000.00. The estimated salary range represents an anticipated range for this position. The actual base salary offered may vary based on a variety of factors.
We offer a competitive total rewards package that includes short-term and long-term incentive programs and a comprehensive benefits package, including medical, dental, and vision coverage, a 401(k) with company match, paid time off, and additional benefits.